The global Recurrent Urinary Tract Infection Treatment Market is experiencing steady growth as the increasing prevalence of recurrent UTIs, growing antibiotic resistance concerns, and advancing therapeutic options drive demand for effective treatment solutions. Valued at approximately USD 1.97 billion in 2025, the market is projected to expand at a CAGR of 5.9% through 2035. The...